The Experimental treatment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
Purpose of study: To determine if Nuedexta exerts a palliative effect on speech, swallowing and salivation in patients with ALS.
Principal Investigator: Dr. Kimberly Goslin
Contact: Providence ALS Research Nurse at 503 962-1171
Sponsor: ALS Association (ALSA) and the Northeast ALS Consortium (NEALS)